Recent News

• 06.18.2025 - 2025 Annual Meeting of Stockholders
• 06.18.2025 - 2025 Annual Meeting of Stockholders
• 06.03.2025 - ASCO Report of Pioneering Treatment of Lymphopenia with Significant Overall Survival Benefit in Advanced Pancreatic Cancer
• 06.03.2025 - ASCO Report of Pioneering Treatment of Lymphopenia with Significant Overall Survival Benefit in Advanced Pancreatic Cancer
• 06.03.2025 - ASCO Report of Pioneering Treatment of Lymphopenia with Significant Overall Survival Benefit in Advanced Pancreatic Cancer
• 06.03.2025 - June 3, 2025 - June 5, 2025 : Jefferies Global Healthcare Conference
• 06.03.2025 - June 3, 2025 - June 3, 2025 : ASCO 2025 Annual Meeting
• 06.03.2025 - June 3, 2025 - June 3, 2025 : ASCO 2025 Annual Meeting
• 06.03.2025 - June 3, 2025 - June 5, 2025 : Jefferies Global Healthcare Conference
• 06.02.2025 - ImmunityBio Receives FDA Expanded Access Authorization for Landmark Treatment of Lymphopenia With ANKTIVA®, the Cancer BioShield™ Platform, in Patients With Solid Tumors

Recent Filings